Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13.11. | Singular Genomics CEO Andrew Spaventa verkauft Aktien im Wert von 15.668 US-Dollar | 2 | Investing.com Deutsch | ||
12.11. | Singular Genomics Systems, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
SINGULAR GENOMICS SYSTEMS Aktie jetzt für 0€ handeln | |||||
04.11. | Singular Genomics Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
19.09. | Singular Genomics Systems, Inc.: Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital | 208 | GlobeNewswire (Europe) | SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower... ► Artikel lesen | |
19.09. | Singular Genomics Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
19.09. | Singular Genomics jumps after Tang's Concentra offers $12 a share | 1 | Seeking Alpha | ||
13.09. | What's Going On With Singular Genomics Stock Friday? | 4 | Benzinga.com | ||
13.09. | Pre-market Movers: Tenon Medical, Vision Marine Technologies, SMX, Singular Genomics Systems, Immuneering | 948 | AFX News | SAN JOSE (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.00 A.M. ET).In the Green Tenon Medical, Inc. (TNON) is up over 350% at $19.80.
Vision... ► Artikel lesen | |
13.09. | Singular Genomics Systems Receives $10/shr Acquisition Proposal From Deerfield; Stock Surges | 2 | RTTNews | ||
12.09. | Singular Genomics receives acquisition proposal from Deerfield | 1 | Seeking Alpha | ||
12.09. | Singular Genomics receives buyout proposal from Deerfield | 1 | Investing.com | ||
12.09. | Singular Genomics Systems, Inc.: Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield | 131 | GlobeNewswire (Europe) | SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower... ► Artikel lesen | |
12.09. | Singular Genomics Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
06.09. | Singular Genomics Systems stock touches 52-week low at $5.76 amid market challenges | 1 | Investing.com | ||
15.08. | Singular Genomics shares hold Buy rating on G4X platform progress | 2 | Investing.com | ||
15.08. | Earnings call: Singular Genomics Q2 results and G4X launch plans | 1 | Investing.com | ||
13.08. | Singular Genomics Systems GAAP EPS of -$8.57 beats by $0.29, revenue of $0.7M beats by $0.29M | 2 | Seeking Alpha | ||
13.08. | Singular Genomics Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
30.07. | Singular Genomics Systems, Inc.: Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024 | 1 | GlobeNewswire (USA) | ||
15.07. | Singular Genomics regains compliance with Nasdaq | 1 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 97,15 | -0,46 % | Die meistgehandelten Produkte: BioNTech verstärkt sich mit Übernahme! | ||
VALNEVA | 2,090 | -1,79 % | Valneva mit Shigella-News: Bringt das die Wende? | Die Valneva Aktie erhielt gestern dringend benötigte Impulse, nachdem sie zuletzt tief gefallen war und zwei Tage in Folge Tagestiefs bei 2,232 bzw. 2,240 Euro markierte. Gestern konnte die Aktie im... ► Artikel lesen | |
NOVAVAX | 7,474 | -2,34 % | AKTIEN IM FOKUS: Impfstoffwerte unter Druck - Trump nominiert Skeptiker | FRANKFURT/NEW YORK (dpa-AFX) - Europäische und US-amerikanische Impfstoff-Aktien haben mit deutlichen Kursverlusten auf die Nominierung des Impfskeptikers Robert F. Kennedy Jr. als US-Gesundheitsminister... ► Artikel lesen | |
EPIGENOMICS | 0,900 | -21,74 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
MAINZ BIOMED | 0,206 | -2,38 % | Mainz Biomed und Thermo Fisher Scientific unterzeichnen Kooperationsvereinbarung | ||
BAVARIAN NORDIC | 25,800 | -0,08 % | Weniger Umsatz als erwartet: Affenpocken-Impfhersteller Bavarian Nordic knallt zweistellig runter | © Foto: Sven Hoppe/dpa - dpa-BildfunkDas dänische Biotechnologieunternehmen Bavarian Nordic meldet für das dritte Quartal deutlich schlechtere Zahlen als erwartet. Die Anteile des Affenpocken-Impfherstellers... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,364 | -1,62 % | Defence Therapeutics Inc.: Defence Therapeutics Announces Securities for Debenture Financing | Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company... ► Artikel lesen | |
BIOMARIN PHARMACEUTICAL | 59,10 | +1,62 % | BioMarin: Real-World Evidence Supports Safety, Efficacy Of VOXZOGO In Children With Achondroplasia | WASHINGTON (dpa-AFX) - BioMarin Pharmaceutical Inc. (BMRN) announced positive and consistent results from multiple real-world evidence studies of VOXZOGO (vosoritide) in children with achondroplasia.... ► Artikel lesen | |
GINKGO BIOWORKS | 6,100 | +0,83 % | Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Drop in Short Interest | ||
RECURSION PHARMACEUTICALS | 6,040 | 0,00 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
BEAM THERAPEUTICS | 24,480 | 0,00 % | Beam Therapeutics Inc. (NASDAQ:BEAM) Sees Large Increase in Short Interest | ||
ONCOLYTICS BIOTECH | 0,950 | +0,53 % | Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2024 Earnings Call Transcript | ||
SPEXIS | 0,032 | 0,00 % | Adhoc: Spexis AG: Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently | Spexis AG / Key word(s): Delisting
Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently.
05-Nov-2024 / 07:15 CET/CEST
Release of an ad hoc announcement... ► Artikel lesen | |
MEREO BIOPHARMA | 3,330 | -1,77 % | Mereo BioPharma Group plc: Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Setrusumab receives Breakthrough Therapy designation from the FDA Cash of $80.5 million as of September 30, 2024, expected to fund operations into 2027 LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mereo... ► Artikel lesen | |
ARCTURUS THERAPEUTICS | 16,190 | 0,00 % | Arcturus Therapeutics Holdings Inc.: Arcturus Therapeutics to Present at Jefferies London Healthcare Conference | Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities... ► Artikel lesen |